These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11268361)

  • 1. Beneficial autoimmune T cells and posttraumatic neuroprotection.
    Schwartz M
    Ann N Y Acad Sci; 2000; 917():341-7. PubMed ID: 11268361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair.
    Schwartz M; Cohen I; Lazarov-Spiegler O; Moalem G; Yoles E
    J Mol Med (Berl); 1999 Oct; 77(10):713-7. PubMed ID: 10606206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity After Ischemic Stroke and Brain Injury.
    Javidi E; Magnus T
    Front Immunol; 2019; 10():686. PubMed ID: 31001280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological approaches to the treatment of spinal cord injury.
    Schwartz M
    BioDrugs; 2001; 15(9):585-93. PubMed ID: 11580302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity.
    Barouch R; Schwartz M
    FASEB J; 2002 Aug; 16(10):1304-6. PubMed ID: 12154003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.
    Schwartz M; Kipnis J
    Neuroscientist; 2002 Oct; 8(5):405-13. PubMed ID: 12374425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial immune activity after CNS injury: prospects for vaccination.
    Schwartz M; Moalem G
    J Neuroimmunol; 2001 Feb; 113(2):185-92. PubMed ID: 11164901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune involvement in CNS trauma is beneficial if well controlled.
    Schwartz M
    Prog Brain Res; 2000; 128():259-63. PubMed ID: 11105685
    [No Abstract]   [Full Text] [Related]  

  • 10. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.
    Schwartz M; London A; Shechter R
    Neuroscience; 2009 Feb; 158(3):1133-42. PubMed ID: 19103265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.
    Moalem G; Leibowitz-Amit R; Yoles E; Mor F; Cohen IR; Schwartz M
    Nat Med; 1999 Jan; 5(1):49-55. PubMed ID: 9883839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury.
    Lü HZ; Xu L; Zou J; Wang YX; Ma ZW; Xu XM; Lu PH
    Brain Behav Immun; 2008 Nov; 22(8):1217-30. PubMed ID: 18625299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.
    Moalem G; Gdalyahu A; Shani Y; Otten U; Lazarovici P; Cohen IR; Schwartz M
    J Autoimmun; 2000 Nov; 15(3):331-45. PubMed ID: 11040074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helping The Body To Cure Itself: Immune Modulation By Therapeutic Vaccination For Spinal Cord Injury.
    Schwartz M
    J Spinal Cord Med; 2003 Jan; 26(sup1):S6-S10. PubMed ID: 27700258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The enigma of arrival: [corrected] the entrance of auto-immune T lymphocytes in central nervous tissues and of their attack against the myelin structures].
    Wekerle H
    C R Biol; 2007 Jan; 330(1):1-12. PubMed ID: 17241944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
    Becher B; Bechmann I; Greter M
    J Mol Med (Berl); 2006 Jul; 84(7):532-43. PubMed ID: 16773356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
    Liblau R; Cassan C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of the immune disorders in primary and repeated craniocerebral trauma].
    Lisianyĭ MI; Rudenko VA; Hniedkova IO; Lisianyĭ OM; Horobets' OV
    Fiziol Zh (1994); 1997; 43(5-6):3-10. PubMed ID: 9463005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic and regional neuroimmune processes in focal CNS lesions].
    Lisianyĭ NI; Rudenko VA; Markova OV; Gnedkova IA; Lisianaia TA; Liubich LD; Gorobets OB; Bel'skaia LN
    Fiziol Cheloveka; 2000; 26(1):92-9. PubMed ID: 10752297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.